Related Experiment Video
Updated: Jul 20, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus
Y M Cho1,2, M D Ritchie3, J H Moore3
1Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-Dong Chongno-Gu, Seoul, 110-744, Korea.
Diabetologia
|January 20, 2004
Summary
Genetic interactions between UCP2 and PPARgamma genes influence Type 2 diabetes risk. Specific genotypes, like UCP2 55 Ala/Val heterozygote and PPARgamma 161 C/C homozygote, were linked to reduced diabetes risk.
Area of Science:
- Genetics
- Metabolic Diseases
- Molecular Biology
Background:
- Type 2 diabetes mellitus (T2DM) is a complex genetic disorder influenced by multiple gene-environment interactions.
- Identifying specific gene-gene interactions is crucial for understanding T2DM etiology.
- Single genetic factors often have limited independent effects on T2DM risk.
Purpose of the Study:
- To identify significant gene-gene interactions associated with the risk of Type 2 diabetes.
- To explore the interplay between candidate genes involved in T2DM pathogenesis.
Main Methods:
- Genotyping of 23 polymorphic loci across 15 candidate genes in 504 T2DM patients and 133 controls.
- Application of multifactor-dimensionality reduction (MDR) to analyze gene-gene interactions among the 23 loci.
- MDR is effective for detecting interactions in case-control studies with smaller sample sizes.
Main Results:
- A significant two-locus interaction was identified between the UCP2 Ala55Val polymorphism and the PPARgamma 161C>T polymorphism.
- This interaction demonstrated high consistency and minimal prediction error in the MDR analysis.
- The combined genotype of UCP2 55 Ala/Val heterozygote and PPARgamma 161 C/C homozygote was associated with a 49% reduced risk of T2DM (OR=0.51, P=0.0016).
Conclusions:
- The study identified a significant gene-gene interaction between UCP2 and PPARgamma in T2DM.
- This finding highlights the importance of considering combined genotypes for T2DM risk assessment.
- Identifying specific genotype combinations could offer a novel approach for identifying individuals at high risk for Type 2 diabetes.
Related Concept Videos
02:01Factorial Design
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
01:17Two-Way ANOVA
The two-way ANOVA is an extension of the one-way ANOVA. It is a statistical test performed on three or more samples categorized by two factors - a row factor and a column factor. Ronald Fischer mentioned it in 1925 in his book 'Statistical Methods for Researchers.'
The two-way ANOVA analysis initially begins by stating the null hypothesis that there is an interaction effect between the two factors of a dataset. This effect can be visualized using line segments formed by joining the means for...
The two-way ANOVA analysis initially begins by stating the null hypothesis that there is an interaction effect between the two factors of a dataset. This effect can be visualized using line segments formed by joining the means for...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.